INCISIVE GENETICS
IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and transformational delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles. The Company's pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases. IG is actively seeking partnerships with pharmaceutical companies developing gene therapies to be enabled by its novel delivery platform.
INCISIVE GENETICS
Industry:
Biotechnology Genetics Health Care Medical Device
Founded:
2018-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.incisivegenetics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.88 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Noel Hall
Noel Hall investment in Seed Round - Incisive Genetics
Sandra MacPherson
Sandra MacPherson investment in Seed Round - Incisive Genetics
Haig Farris
Haig Farris investment in Seed Round - Incisive Genetics
Noel Hall
Noel Hall investment in Angel Round - Incisive Genetics
entrepreneurship@UBC
entrepreneurship@UBC investment in Pre Seed Round - Incisive Genetics
Official Site Inspections
http://www.incisivegenetics.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Incisive Genetics"
Who We Are - Incisive Genetics
Gene editing is a completely new approach to disease management, and this therapeutic area is evolving at an incredibly rapid pace. Thanks to CRISPR technology, a simple yet powerful tool for editing genomes, science that was …See details»
Incisive Genetics - Crunchbase Company Profile
Contact Email [email protected] IG is focused on developing a cutting-edge non-viral delivery platform for genetic therapies. This disruptive and …See details»
OUR TEAM - Incisive Genetics
The IG team is a cross-functional group of experts spanning all aspects of therapeutic development, from pre-clinical scientific investigations and human clinical testing, to …See details»
Incisive Genetics - LinkedIn
Incisive Genetics | 467 followers on LinkedIn. Delivering the Promise of Genetic Medicine | We are a Vancouver, Canada-based biotech firm focused on developing our innovative lipid nanoparticle ...See details»
Incisive Genetics - VentureRadar
"Incisive Genetics Inc. (IG) is a Canadian biotech firm that is focused on developing its innovative lipid nanoparticle (LNP) delivery platform for genetic therapies.See details»
Incisive Genetics Inc. | Vancouver, BC, Canada Startup - Gust
Website incisivegenetics.com; Company Summary Incisive Genetics is developing a delivery platform for genetic therapies. This disruptive and transformational lipid nanoparticle (LNP) …See details»
Incisive Genetics - PitchBook
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; EP-4463555-A1: Gene editing reporter system and guide rna and composition related thereto; composition and method for knocking out dna with more than …See details»
Incisive Genetics - Craft
Incisive Genetics is a biotech firm that develops lipid nanoparticle (LNP) delivery platform for genetic therapies. Its platform enables a one-step encapsulation of the active CRISPR …See details»
Incisive Genetics - Overview, News & Similar companies - ZoomInfo
Jun 28, 2021 Incisive Genetics contact info: Phone number: (604) 409-0660 Website: www.incisivegenetics.com What does Incisive Genetics do? Incisive Genetics, a privately held …See details»
Incisive Genetics, Author at Life Sciences British Columbia
Jul 12, 2021 At Incisive Genetics (IG) we are focused on developing our innovative lipid nanoparticle (LNP) delivery platform for genetic therapies. We believe our proprietary platform …See details»
Incisive Genetics
INCISIVE GENETICS ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD AND APPOINTMENT OF DR. MICHAEL R. HAYDEN AS CHAIRPERSON. Prominent Leaders in …See details»
Incisive Genetics Announces The Appointment Of Dr. Kevin
Jun 7, 2021 www.incisivegenetics.com. × Modal title. Organization Profile. Incisive Genetics. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET Contact Us Become a Client; Request a …See details»
Incisive Genetics Announces The Appointment Of Dr. Kevin Chow …
Jun 7, 2021 Key addition to Leadership Team brings more than two decades of industry experience in biotechnology corporate development and strategy VANCOUVER,...See details»
Incisive Genetics
Pamela Wagner is the Director of R&D Operations at Incisive Genetics Inc. She co-founded the company and co-invented the Incisive Delivery System™See details»
Incisive Genetics Announces Formation Of Scientific Advisory
Jun 28, 2021 "Incisive Genetics' platform technology represents a very promising avenue for gene therapy," said Dr. Hayden. "I look forward to leading the Scientific Advisory Board and …See details»
Incisive Genetics
INCISIVE GENETICS ANNOUNCES THE CLOSE OF A $500,000 FIRST PHASE OF A $2 MILLION ANGEL INVESTMENT. Biotech company IG, specializing in the research and …See details»
Incisive Genetics Announces Closing Of A $2.5 Million Seed
VANCOUVER, BC, July 12, 2021 /CNW/ -- Incisive Genetics Inc. ("IG"), a privately held biotech company specializing in the research and development of a novel non-viral delivery platform …See details»
Incisive Genetics
INCISIVE GENETICS ANNOUNCES THE APPOINTMENT OF DR. KEVIN CHOW AS PRESIDENT Key addition to Leadership Team brings more than two decades of industry …See details»
Incisive Genetics Announces Closing Of A $2.5 Million Seed …
VANCOUVER, BC, July 12, 2021 /PRNewswire/ -- Incisive Genetics Inc. ("IG"), a privately held biotech company specializing in the research and development of a novel non-viral delivery …See details»